42 resultados para Multiplicative linear secret sharing schemes
Resumo:
Dissertação para obtenção do Grau de Mestre em Engenharia Electrotécnica e Computadores
Resumo:
Dissertação para obtenção do Grau de Mestre em Engenharia Informática
Resumo:
A brief introduction to the fractional continuous-time linear systems is presented. It will be done without needing a deep study of the fractional derivatives. We will show that the computation of the impulse and step responses is very similar to the classic. The main difference lies in the substitution of the exponential by the Mittag-Leffler function. We will present also the main formulae defining the fractional derivatives.
Resumo:
Dissertação apresentada à Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa para obtenção do Grau de Mestre em Engenharia Mecânica
Resumo:
Dissertação apresentada para obtenção do Grau de Doutor em Matemática, Estatística, pela Universidade Nova de Lisboa, faculdade de Ciências e Tecnologia
Resumo:
IEEE CIRCUITS AND SYSTEMS MAGAZINE, Third Quarter
Resumo:
Ramsey pricing has been proposed in the pharmaceutical industry as a principle to price discriminate among markets while allowing to recover the (fixed) R&D cost. However, such analyses neglect the presence of insurance or the fund raising costs for most of drug reimbursement. By incorporating these new elements, we aim at providing some building blocks towards an economic theory incorporating Ramsey pricing and insurance coverage. We show how coinsurance affects the optimal prices to pay for the R&D investment. We also show that under certain conditions, there is no strategic incentive by governments to set coinsurance rates in order to shift the financial burden of R&D. This will have important implications to the application of Ramsey pricing principles to pharmaceutical products across countries.
Resumo:
The Janssen-Cilag proposal for a risk-sharing agreement regarding bortezomib received a welcome signal from NICE. The Office of Fair Trading report included risk-sharing agreements as an available tool for the National Health Service. Nonetheless, recent discussions have somewhat neglected the economic fundamentals underlying risk-sharing agreements. We argue here that risk-sharing agreements, although attractive due to the principle of paying by results, also entail risks. Too many patients may be put under treatment even with a low success probability. Prices are likely to be adjusted upward, in anticipation of future risk-sharing agreements between the pharmaceutical company and the third-party payer. An available instrument is a verification cost per patient treated, which allows obtaining the first-best allocation of patients to the new treatment, under the risk sharing agreement. Overall, the welfare effects of risk-sharing agreements are ambiguous, and care must be taken with their use.
Resumo:
Signal Processing, Vol. 83, nº 11
Resumo:
Nonlinear Dynamics, Vol. 29
Resumo:
IEE Proceedings - Vision, Image, and Signal Processing, Vol. 147, nº 1
Resumo:
IEE Proceedings - Vision, Image, and Signal Processing, Vol. 147, nº 1
Resumo:
Nonlinear Dynamics, Vol. 38
Resumo:
Mestrado Integrado em Engenharia Electrotécnica e de Computadores
Resumo:
Proceedings of the European Control Conference, ECC’01, Porto, Portugal, September 2001